Atrys Health (ATRY.MC) Osake Kurssi
Atrys Health Kurssi
Liikevaihto on kasvanut 45,5 % vuodessa viimeisten 13 vuoden aikana 141,01 M EUR:een. Osakekohtainen tulos on laskenut 37,2 % vuodessa viimeisten 6 vuoden aikana. Atrys Healthn nettomarginaali on nyt −71,1 %, laskenut −19,2 %:sta muutama vuosi sitten. Analyytikoiden mediaanitavoitehinta on 5,76 EUR, eli yli nykyhintaa 127,3 %. 10 analyytikosta 9 suosittaa ostoa — kokonaiskonsensus on Osta.
Atrys Health osakekurssi
Atrys Health liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Atrys Health -osakkeesta
The business model of Atrys Health SA revolves around providing advanced medical services and solutions. Atrys is a leading medical technology company that offers specialized diagnostic and therapeutic services, particularly in the fields of oncology, radiology, and molecular medicine. They utilize cutting-edge technology and expertise to deliver accurate diagnoses and personalized treatments to patients. Atrys operates through a network of clinics, laboratories, and telemedicine platforms, ensuring accessibility and quality healthcare solutions. With a focus on precision medicine and innovation, Atrys Health SA aims to improve patient outcomes and contribute to the advancement of the medical field.
Atrys Health SA is primarily active in the healthcare industry.
The main competitors of Atrys Health SA in the market include [Competitor 1], [Competitor 2], and [Competitor 3]. These competitors offer similar products and services, which can create a competitive landscape for Atrys Health SA. However, Atrys Health SA stands out with its unique offerings, such as [mention a unique feature or service]. By maintaining its competitive edge and constantly innovating, Atrys Health SA remains a prominent player in the market, outshining its rivals and ensuring its continued success.
Atrys Health SA is a prominent healthcare company with a rich history and background. Founded in 2008, Atrys Health specializes in medical diagnostic services and telemedicine solutions. With a focus on personalized medicine, the company employs advanced technology and innovative approaches to improve patient care and outcomes. Atrys Health has established a solid reputation in the market by providing high-quality medical services to both public and private institutions. Through strategic partnerships and acquisitions, the company has expanded its operations internationally, becoming a global leader in the field. Atrys Health SA is committed to enhancing healthcare accessibility and efficiency, making significant contributions to the medical industry.
Atrys Health SA, a leading healthcare company, has achieved several significant milestones. It has successfully expanded its reach and offerings, establishing a strong global presence. The company has pioneered advanced medical solutions, leveraging state-of-the-art technology and innovative healthcare practices. Atrys Health SA has consistently focused on delivering excellent patient outcomes, offering personalized diagnostic and treatment services. Its commitment to research and development has led to groundbreaking advancements in areas like molecular diagnostics and telemedicine. With a strong emphasis on collaboration and partnerships, Atrys Health SA continues to revolutionize the healthcare industry, improving access to high-quality medical services worldwide.
Atrys Health SA is primarily present in Spain and several other countries in Europe and Latin America.
Atrys Health SA represents values of excellence, innovation, and patient-centricity. With a dedicated focus on providing advanced medical solutions, Atrys Health combines cutting-edge technology with the expertise of highly skilled professionals. Their corporate philosophy revolves around delivering high-quality healthcare services, improving patient outcomes, and enhancing overall well-being. Atrys Health prioritizes integrity, transparency, and ethical practices in every aspect of their operations. By continuously investing in research and development, Atrys Health aims to revolutionize the healthcare industry and become a global leader in personalized medicine and telemedicine solutions.
Analyytikot asettavat tällä hetkellä Atrys Health-osakkeelle keskimääräisen tavoitehinnan 5,81 EUR (mediaani: 5,76 EUR), mikä merkitsee +129,3 % viimeisimpään hintaan verrattuna. Konsensus perustuu 10 analyytikkoarvioon.
10 analyytikkoa arvioi tällä hetkellä Atrys Health-osaketta: 9 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Atrys Health-yhtiöltä 151,69 M EUR liikevaihtoa ja 0,01 EUR osakekohtaista tulosta.
Atrys Health-osake (ATRY.MC) on listattuna 3 pörssissä, muun muassa: Frankfurt (A2T.F), Madrid (ATRY.MC).
Atrys Health SA is a leading European healthcare company that provides innovative solutions in the field of precision medicine. The company operates in various sectors, including diagnostics, oncology, radiotherapy, and telemedicine. Atrys Health aims to find new ways to improve healthcare by using groundbreaking technology and scientific knowledge. Answer: Atrys Health SA is a leading European healthcare company that provides innovative solutions in the field of precision medicine. The company operates in various sectors, including diagnostics, oncology, radiotherapy, and telemedicine. Atrys Health aims to improve healthcare by using groundbreaking technology and scientific knowledge.
odotettu liikevaihto Atrys Health on 151,69 M EUR. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Atrys Health on 881 165,40 EUR. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Atrys Health:n hinta-voitto-suhde (P/E) on tällä hetkellä 218,45. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Atrys Health-osakkeen arvostusta.
Atrys Health:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,27. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Atrys Health-osakkeen arvostuskennuslukuna.
Atrys Health:n Eulpool-laatuscore on 2/10.
Atrys Health:n ISIN on ES0105148003. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Atrys Health:n WKN on A2JJ74. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Atrys Health:n ticker on ATRY.MC. Tämä pörssinoteeraus käytetään Atrys Health-osakkeiden kauppaan pörssissä.
Atrys Health osake
Atrys Health vertaisryhmä
Atrys Health Ticker
Atrys Health FIGI
Kaikki tunnusluvut ja syvällinen analyysi Atrys Health:sta
Meidän osakeanalyysimme Atrys Health-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Atrys Health:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: